相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis
Changfu Yao et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial
Kristin B Highland et al.
Lancet Respiratory Medicine (2021)
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
Dinesh Khanna et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Predictors of progression in systemic sclerosis patients with interstitial lung disease
Oliver Distler et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases
Boris Hinz et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Cell senescence and fibrotic lung diseases
Rui-Ming Liu et al.
EXPERIMENTAL GERONTOLOGY (2020)
Systemic sclerosis-associated interstitial lung disease
Apostolos Perelas et al.
LANCET RESPIRATORY MEDICINE (2020)
Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures
Haruhiko Furusawa et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Pulmonary hypertension secondary to pulmonary fibrosis: clinical data, histopathology and molecular insights
Gregoire Ruffenach et al.
RESPIRATORY RESEARCH (2020)
Treatment of systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials
David Roofeh et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2020)
Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung disease
Dinesh Khanna et al.
RHEUMATOLOGY (2019)
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
Frances Humby et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis
Su-Jin Moon et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Anna-Maria Hoffmann-Vold et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
Astrid Weiss et al.
NATURE COMMUNICATIONS (2019)
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 1. Introduction
Sung-Woo Park et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2019)
Molecular classification of Crohn's disease reveals two clinically relevant subtypes
Matthew Weiser et al.
GUT (2018)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts
Yanni Wang et al.
EXPERIMENTAL CELL RESEARCH (2018)
Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumours
Olli-Pekka Pulkka et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Network-based approach to prediction and population-based validation of in silico drug repurposing
Feixiong Cheng et al.
NATURE COMMUNICATIONS (2018)
A systematic survey of centrality measures for protein-protein interaction networks
Minoo Ashtiani et al.
BMC SYSTEMS BIOLOGY (2018)
Major lung complications of systemic sclerosis
Christopher P. Denton et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis
Martina Korfei et al.
PLOS ONE (2018)
Matrix abnormalities in pulmonary fibrosis
Chandak Upagupta et al.
EUROPEAN RESPIRATORY REVIEW (2018)
FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis
Hamza M. Al-Tamari et al.
EMBO MOLECULAR MEDICINE (2018)
diffuStats: an R package to compute diffusion-based scores on biological networks
Sergio Picart-Armada et al.
BIOINFORMATICS (2018)
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?
Brandon J. Aubrey et al.
CELL DEATH AND DIFFERENTIATION (2018)
A functional genomics predictive network model identifies regulators of inflammatory bowel disease
Lauren A. Peters et al.
NATURE GENETICS (2017)
Chasing the thermodynamical noise limit in whispering-gallery-mode resonators for ultrastable laser frequency stabilization
Jinkang Lim et al.
NATURE COMMUNICATIONS (2017)
A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis
Jaclyn N. Taroni et al.
GENOME MEDICINE (2017)
Idiopathic pulmonary fibrosis
Fernando J. Martinez et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Mergeomics: multidimensional data integration to identify pathogenic perturbations to biological systems
Le Shu et al.
BMC GENOMICS (2016)
Gene expression profiling of asthma phenotypes demonstrates molecular signatures of atopy and asthma control
Judie A. Howrylak et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
VCAM-1 is a TGF-β1 inducible gene upregulated in idiopathic pulmonary fibrosis
Marianna Agassandian et al.
CELLULAR SIGNALLING (2015)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) (vol 46, pg 903, 2015)
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma
Amitabh Sharma et al.
HUMAN MOLECULAR GENETICS (2015)
Inhibition of fibronectin deposition improves experimental liver fibrosis
Eva Altrock et al.
JOURNAL OF HEPATOLOGY (2015)
Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis
Martina Korfei et al.
THORAX (2015)
Systemic sclerosis
Yannick Allanore et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats
S. Jacquin et al.
PLOS ONE (2015)
Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis How Similar and Distinct?
Erica L. Herzog et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer's Disease
Bin Zhang et al.
CELL (2013)
Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
Gisela E. Lindahl et al.
RESPIRATORY RESEARCH (2013)
Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis
Ivana V. Yang et al.
THORAX (2013)
Gene Expression Profiling in the Lungs of Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis
Marco Mura et al.
CHEST (2012)
Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis
Nina M. Patel et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice
Shiro Mizuno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Network medicine: a network-based approach to human disease
Albert-Laszlo Barabasi et al.
NATURE REVIEWS GENETICS (2011)
Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis
I Inoshima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
分享论文
